Ascendis Pharma A/S ASND

$ 123.33 -0.85%

Annual report 2023
added 11-16-2024

Ascendis Pharma A/S Financial Statements 2011-2024 | ASND

Annual Financial Statements Ascendis Pharma A/S

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	-	-	7.37 B	8.44 B	6.47 B	2.57 B	1.35 B	561 M	453 M	336 M	-	-	-
Shares	-	-	54.8 M	50.6 M	46.5 M	41.1 M	33.6 M	26.6 M	23.8 M	16.9 M	-	-	-
Historical Prices	142	91.3	135	167	139	62.6	40.1	20.2	18.3	-	-	-	-
Net Income	-	-	-384 M	-419 M	-218 M	-130 M	-124 M	-68.5 M	-32.9 M	-9.66 M	4.08 M	1.25 M	-
Revenue	267 M	51.2 M	7.78 M	6.95 M	13.4 M	10.6 M	1.53 M	4.61 M	8.12 M	14 M	20.4 M	15.6 M	-
Cost of Revenue	-	-	3.52 M	-	-	-	-	-	-	-	-	-	-
Gross Profit	222 M	39 M	4.26 M	6.95 M	13.4 M	-	-	-	-	14 M	20.4 M	15.6 M	-
Operating Income	-	-	-452 M	-331 M	-227 M	-155 M	-112 M	-72.9 M	-41.8 M	-	-	-	-
Interest Expense	44.1 M	30.7 M	3.91 M	1.92 M	1.22 M	127 K	97 K	5 K	6 K	-	-	-	-
EBITDA	-	-	-452 M	-331 M	-227 M	-155 M	-112 M	-72.2 M	-41.3 M	-11.5 M	5.68 M	1.94 M	-
Operating Expenses	-	-	-	338 M	240 M	165 M	113 M	77.5 M	49.9 M	26 M	15.1 M	14.1 M	-
General and Administrative Expenses	-	-	160 M	76.7 M	48.5 M	25.1 M	13.5 M	11.5 M	9.42 M	6.27 M	2.42 M	2.69 M	-

All numbers in EUR currency

Quarterly Income Statement Ascendis Pharma A/S

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	56.7 M	-	54.6 M	53.8 M	53.8 M	-	52.7 M	48.2 M	48 M	-	47.6 M	47.2 M	43.4 M	-	41.9 M	41.7 M	38.7 M	-	32.6 M	32.5 M	32.4 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-125 M	-	-80.3 M	-134 M	-62.8 M	-	-122 M	-94.9 M	-63.3 M	-	-25.1 M	-58.9 M	-53.6 M	-	-34 M	-22.8 M	-41.4 M	-	-33.9 M	-30.7 M	-25.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	6.83 M	-	1.11 M	1.02 M	746 K	-	2.76 M	1.44 M	2.22 M	-	2.24 M	3.21 M	5.41 M	-	20 K	18 K	28 K	-	434 K	444 K	372 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	4.25 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	2.58 M	-	-	-	746 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-128 M	-	-96.9 M	-118 M	-125 M	-	-78.8 M	-82.9 M	-73.2 M	-	-54 M	-51.6 M	-56.3 M	-	-38.3 M	-45.4 M	-35.2 M	-	-31.5 M	-24.7 M	-23.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-128 M	-	-96.9 M	-118 M	-125 M	-	-78.8 M	-82.9 M	-73.2 M	-	-54 M	-51.6 M	-56.3 M	-	-38.3 M	-45.4 M	-35.2 M	-	-31.5 M	-24.7 M	-23.6 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	47.4 M	-	39.3 M	35.3 M	37.2 M	-	17.5 M	20.8 M	17.9 M	-	10 M	11 M	10.4 M	-	6.8 M	5.23 M	4.66 M	-	2.84 M	3.23 M	3.32 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in EUR currency